Immunosuppression and Heart Transplantation
Immunosuppression and Heart Transplantation
Since the first human heart transplant in 1967, immense advancements have been made in the field of immunosuppression. This chapter provides an in-depth analysis of the use of immunosuppressive agents in heart transplant recipients. Evidence regarding maintenance immunosuppressive regimens, the efficacy of induction immunosuppression and corticosteroid weaning, as well as the use of distinct immunosuppression regimens within select patient populations is summarized. This chapter helps elucidate the data regarding contemporary protocols in cardiac transplantation.
- Tufts Medical Center United States
Graft Rejection, Immunosuppression Therapy, Sirolimus, Calcineurin Inhibitors, Cyclosporine, Heart Transplantation, Humans, Mycophenolic Acid, Immunosuppressive Agents
Graft Rejection, Immunosuppression Therapy, Sirolimus, Calcineurin Inhibitors, Cyclosporine, Heart Transplantation, Humans, Mycophenolic Acid, Immunosuppressive Agents
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).11 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!